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Five years after the apparent end of the major 1995
Venezuelan equine encephalitis (VEE) epizootic/epidemic,
focal outbreaks of equine encephalitis occurred in
Carabobo and Barinas States of western Venezuela. Virus
isolates from horses in each location were nearly identical
in sequence to 1995 isolates, which suggests natural per-
sistence of subtype IC VEE virus (VEEV) strains in a genet-
ically stable mode. Serologic evidence indicated that
additional outbreaks occurred in Barinas State in 2003.
Field studies identified known Culex (Melanoconion) spp.
vectors and reservoir hosts of enzootic VEEV but a dearth
of typical epidemic vectors. Cattle serosurveys indicated
the recent circulation of enzootic VEEV strains, and possi-
bly of epizootic strains. Persistence of VEEV subtype IC
strains and infection of horses at the end of the rainy sea-
son suggest the possibility of an alternative, cryptic trans-
mission cycle involving survival through the dry season of
infected vectors or persistently infected vertebrates.
V
enezuelan equine encephalitis (VEE) is a reemerging,
mosquitoborne viral disease of humans and equines
(1). Equines serve as highly efficient amplification hosts
for mosquitoborne transmission of 2 VEE virus (VEEV)
epidemic subtypes, IAB and IC. Humans become infected
primarily through the bites of the large numbers of mos-
quitoes that can be infected by viremic horses. Enzootic
VEEV strains of variants ID and IE, closely related anti-
genically and genetically to each other and to variants IAB
and IC, circulate in lowland tropical forests and swamps
among small mammals but are incapable of equine ampli-
fication to cause epidemics (2).
After a long period of inactivity from 1973 to 1992,
recent outbreaks in Venezuela (3,4), Colombia (5), and
Mexico (6) underscore the continued threat of VEE in the
Americas. Because recent outbreaks have occurred sporad-
ically, often with many intervening years of epidemic inac-
tivity, the origin of strains of VEEV subtypes IAB and IC
was enigmatic for many years. Of several hypotheses pro-
posed (7), only 2 have been supported by antigenic and
genetic comparisons of VEEV strains and experimental
studies. The first hypothesis, suggested by sequence data,
is that some epidemics that occurred between the first iso-
lation of VEEV in 1938 and the last outbreak involving a
strain of the IAB subtype in 1973 resulted from the use of
incompletely inactivated vaccines produced from strains
of VEEV subtype IAB (8). The lack of VEEV subtype IAB
outbreaks since inactivated virus vaccines were replaced
by the TC-83 attenuated vaccine strain (a subtype IAB
virus) in the early 1970s also supports this hypothesis. The
second hypothesis, supported by genetic studies, is that
epizootic/epidemic (henceforth called epidemic) subtype
IAB and IC VEEV strains arise through mutation from
enzootic subtype ID VEEV strains (9). The strongest such
evidence links a small, 1992-93 Venezuelan VEE outbreak
caused by a subtype IC virus strain to sympatric strains of
enzootic subtype ID virus (3,10).
The last major VEE epidemic began in April 1995 in
the northern Venezuelan state of Falcon and spread
throughout most of northern Venezuela and into La Guajira
peninsula of northeastern Colombia to cause ≈75,000–
100,000 human cases with ≈300 deaths (Figure 1) (4,5).
Although the total number of equine cases was not report-
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1995 in Trujillo, Portuguesa, Cojedes, and Guarico States
of Venezuela. After the apparent end of the 1995 outbreak,
no confirmed epidemic or epizootic VEE occurred in
South America for >4 years.
During December 1999 and February 2000, small,
focal outbreaks of equine encephalitis were reported dur-
ing the end of the rainy season and beginning of the dry
season in Carabobo and Barinas States of Venezuela
(Figure 1). Similar outbreaks occurred in Barinas State
during October 2003. Clinical case descriptions, viral
genetic studies, and preliminary surveillance in the region
suggested persistence of VEEV subtype IC after 1995 in a
cryptic transmission cycle.
Materials and Methods
Collection of Animal Samples
Arboviral surveillance was conducted in 2 regions of
Barinas State: 1) Zamora and Obispos Counties and 2)
Arismendi County (Figure 1). Four farms were studied in
Zamora and Obispos Counties from April 2001 to October
2003: 1) El Relámpago (7°57′24′′N, 70°59′20′′W); 2) El
Porvenir (7°49′–8°49′N; 70°37′–70°55′W); 3) La
Grandeza (7°50′13′′N, 70°44′25′′W), and 4) Boca de Quiu
(7°51′–57′′N, 70°43′52′′W). In Arismendi County, studies
occurred in October 2003, at the end of the outbreak, on 4
farms: 1) Los Mesones (8°31′52′′N, 68°21′49′′ W); 2) Mis
Cantares (8°24′09′′N, 68°17′93′′W); 3) Don Eduardo
(8°28′36′′N, 68°21′94′′), and 4) La Espuela (8°28′72′′N,
68°21′68′′W, including equines obtained from El
Diamante). These farms, typical of the region, focus main-
ly on cattle production; equines are maintained for herding.
At each site, Syrian golden hamsters were exposed in
coquito cages (11) for 7 days. Cages were suspended
1.2–1.5 m above the ground in transects at 20- to 25-m
intervals, and hamsters were inspected and fed carrots
daily. Blood samples were collected by cardiac puncture
from moribund hamsters and from those surviving expo-
sure; heart and spleen samples were then dissected and
preserved in liquid nitrogen. The maintenance and care of
animals complied with guidelines of the University of
Texas Medical Branch and the Instituto Nacional de
Higiene.
Parallel to the hamster transects, Sherman and
Tomahawk traps were used for collecting small mammals,
as described previously (12). Animals were bled by cardiac
puncture and identified by using taxonomic keys (13,14). 
Mosquito Collections
Mosquitoes were collected with CDC light traps (15)
baited with dry ice and suspended ≈1.5 m above the
ground. Mosquitoes were identified by using taxonomic
keys (16–19) and reference collections (20).
Virus Isolations and Identification
Sera and tissues from equines, sentinel hamsters, and
wild rodents were injected into 1- to 3-day-old mice or
African green monkey kidney (Vero) cells for virus isola-
tion. Viruses indicated by mouse deaths or cytopathic
effects in cell culture were identified by hemagglutination
inhibition (HI) tests. Subtypes of the VEEV isolates were
determined by immunofluorescence by using monoclonal
antibodies (MAbs), as described previously (21), and by
amplifying by reverse transcriptase–polymerase chain
reactions (RT-PCR) a portion of the PE2 envelope
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Figure 1. Map of Venezuela showing
locations of the 1995 Venezuelan equine
encephalitis outbreak and the small out-
breaks of 2000 and 2003, along with sur-
veillance study sites.glycoprotein precursor gene, followed by sequencing and
phylogenetic analyses, as described previously (22).
Genetic Analyses of Virus Isolates
The complete genomes or partial PE2 envelope glyco-
protein precursor sequences of VEEV strains were ampli-
fied by RT-PCR using Superscript reverse transcriptase
(BRL, Bethesda, MD, USA) and Pfu polymerase
(Stratagene, La Jolla, CA, USA), as described previously
(23). After electrophoresis, amplicons were extracted from
1% agarose gels and sequenced directly by using previous-
ly described primers (23) and the Applied Biosystems
(Foster City, CA, USA) Prism automated DNAsequencing
kit to produce consensus sequences. Genomic sequences,
excluding the 5′ terminal 20 nucleotides (nt) derived from
the primer, or PE2 sequences, were submitted to the
GenBank library under accession numbers AY973944 and
AY986475. Sequences were aligned with homologous
VEEV sequences in the GenBank library and analyzed by
using neighbor-joining and maximum parsimony methods
implemented in the PAUP 4.0 software package (24) and
Bayesian methods with MrBayes 3 (25). 
Antibody Detection and Characterization
Serum samples were screened for VEEV antibodies by
using HI with antigens prepared from the TC-83 attenuat-
ed virus vaccine strain and the South American eastern
equine encephalitis virus strain C-49 (26). Antibodies from
serum samples with titers >1:20 were confirmed by using
80% plaque reduction neutralization tests (PRNTs). To
determine the VEEV subtypes that produced reactive sera,
a blocking enzyme-linked immunosorbent assay (ELISA)
with purified VEEV antigens and enzootic- or epidemic-
specific MAbs (21) was used, as described previously (27).
Negative control serum specimens were obtained from




In February 2000, the Venezuelan Animal Health
Service received a report of an equine encephalitis out-
break, consistent with VEE, on the Bella Vista farm in the
Curito Abajo area of Zamora County, Barinas State.
Simultaneously, another outbreak occurred on the Los
Cerros farm in Obispos County (Figure 1). Five serum
specimens were collected from stablemates of affected
horses on the Bella Vista farm; 2 yielded VEEV isolates.
One brain sample collected at necropsy during April 2000
on the Los Cerros farm yielded VEEV. Suspected VEE
was reported in Obispos, Zamora, Pedraza, and Miranda
municipalities before these VEEV isolates were confirmed
at the Instituto Nacional de Investigaciones Agropecuarias
in April 2000. In addition, retrospective examination of
epidemiologic records showed suspected VEE cases in
Zamora County (Curito Abajo) since December 1999.
After the February 2000 outbreaks, 8 additional foci
with 35 fatal equine cases were reported: 3 outbreaks in
Zamora (15 deaths), 2 in Obispos (13 deaths), 2 in Pedraza
(7 deaths), and 1 (no deaths) in Sucre County. Regional
equine vaccination coverage with the strain TC-83 attenu-
ated virus vaccine was 24% before the outbreaks, and
additional vaccination initiated around all apparent foci in
early 2000 increased coverage to 51%.
A geographically distant equine case consistent with
VEE occurred in April 2000 in Carabobo State (Figure 1).
The affected horse had been moved from south Guarico
State (borders Obispos County of Barinas State) 10 days
before onset of disease. Virus was isolated from its brain
after euthanization and from the serum of a recently vacci-
nated stablemate. Another equine death had occurred on
the same farm, but the horse had been incinerated before
the cause of death could be confirmed.
Another outbreak consistent with VEE was reported in
October 2003 in northeastern Barinas State around the
town of Arismendi and along the nearby Guanare River
basin (Figure 1). Because the affected farms were difficult
to access and farmers did not initially report the cases to
avoid equine quarantines, samples from affected horses
were not obtained. 
Equine Serology
Atotal of 619 equine serum specimens from 8 different
municipalities in Barinas State were tested for VEEV and
eastern equine encephalitis virus (EEEV) antibodies by
using HI (Table 1). Zamora and Pedraza municipalities
showed the highest rates of VEEV seropositivity (44% and
48%, respectively); although vaccination was ongoing at
the time of sampling, and some seropositivity undoubted-
ly resulted from vaccination, vaccine coverage of only
≈24% suggested that some horses were naturally infected.
The blocking ELISA (27) cannot distinguish between
strain TC-83 and subtype IC VEEV infections, so the
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determined.
Surveillance 
To investigate circulation of VEEV, small mammals,
known to be reservoir hosts of VEEV, and mosquitoes
were trapped at 4 sites near the equine cases. Bovines <2
years of age that lived on the same farm for their entire life
were bled as sentinels to detect recent VEEV circulation.
The region of the first outbreak in 2000 included a part of
Zamora and Obispos Counties, formerly included in the
Ticoporo Forest Reserve (previously a rainforest, 8°12′N/
70°56′W) between the Quiu and Michay Rivers, on the
border between the western Llanos (plains and savannas)
and the southern Andes Mountains. This area has been
deforested for timber, cattle ranching, and crop farming,
leaving only forest fragments and gallery forests with
slopes of <1% grade and an altitude of ≈200 m. The forest-
ed area decreased from 186,000 hectares (ha) in 1955 to
5,000 ha in 2002 (http://www.tierramerica.net/2002/
1124/ecobreves.shtml). 
The Barinas State rainy season is from April to
December, and the dry season is from January to March,
with mean temperatures of 22°C to 30°C. Annual precipi-
tation averages 1,729–1,995 mm. The flora are typical of
the Llanos and lowland Andean Mountains, including
Ceiba pentadra, Bombacopsis quinata, Spondia mombin,
Chrysophyllum sericeum, Pouteria anibaefolia, Guazuma
tomentosa,  Attalea maracaibensis, and Roystonea
venezuela. During the end of the rainy season, rivers flood
adjacent lowland forests and generate habitat for water let-
tuce (Pistia stratiotes), a floating plant used as a breeding
site by some Culex (Melanoconion) mosquito species.
The region of the second VEE outbreak in 2000
(Arismendi County) also comprises lowland savannas in
the Guanare River basin and includes extensive cattle pro-
duction and fragmented forests resulting from deforesta-
tion. This part of Barinas State borders Guarico, Cojedes,
and Portuguesa States to the north and northwest, and
Apure State to the south (Figure 1). The flora is character-
istic of lowland Llanos (95-m altitude) and flooded savan-
nas:  Copernicia tectorum (Llanos palms), Hymenachne
amplexicaulis, Leersia hexandra, and Luziola spruceana.
The climate is similar to that described above.
Mammal Collections
A total of 130 small mammals were collected during
6,600 trap-nights, for a success rate of 1.9%. The captures
and serologic data are shown in Table 2. The spiny rat
(Proechimys guairae) and the cotton rat (Sigmodon
hispidus), both belonging to known enzootic VEEV reser-
voir genera (12,28,29), as well as the cane mouse
(Zygodontomys brevicauda), were abundant at most sites.
No virus was isolated from wild mammals; HI antibodies
to VEEV were detected in 4 (6.8%) of 58 P. guairae, 1
(25%) of 4 Didelphis marsupialis, and 1 (6.6%) of 15 S.
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was confirmed by PRNT (<20). No EEEV-reactive anti-
bodies were detected. These results suggest either very low
VEEV antibody titers in some rodents or nonspecific HI
reactivity.  
Bovine Serology
Bovines are effective VEE sentinels because they are
naturally infected and seroconvert but no disease develops
and they are not vaccinated (30). We bled cattle <2 years
of age that had resided on the same farm for their entire
life. The Zamora site showed no evidence of bovine
seropositivity, with 0 of 4 positive for VEEV antibodies in
May and 0 of 20 in September 2003 (Table 2). However,
the Arismendi site had a 25% bovine VEEV seropositivity
rate (12/48) from October to November 2003, and all pos-
itive serum samples were negative for EEEV. To determine
whether the seropositive cattle were infected by enzootic
or epidemic (subtype IC) VEEV strains, we used a block-
ing ELISA that distinguishes antibodies based on their
ability to block the reaction of subtype-specific monoclon-
al antibodies (27). Five of the 8 PRNT-positive bovine
serum specimens had consistently higher blocking activity
against the enzootic virus-specific MAb, indicating expo-
sure to enzootic VEE-complex alphaviruses (Table 3).
However, 2 samples (166, 167) had similar blocking activ-
ities against both enzootic and epidemic virus–specific
MAbs, which suggests either infection with both enzootic
and epidemic VEEV phenotypes or nonspecific reactivity
against 1 subtype.
Mosquito Collections
Three CO2-baited CDC light traps were stationed for 2
consecutive days on each farm to assess possible VEEV
vectors as follows: May, June, and September–October,
2003 (Zamora County); October–November 2003
(Arismendi); and December 2003 (Obispos). These
months correspond to the dry season and the rainy season.
Maximum catches were obtained in December 2002 and
November 2003, at the end of the rainy season. A total of
21 mosquito species and 5 unidentified taxa (to species
level) were collected (Table 4). The most abundant species
captured were Cx. (Melanoconion) dunni, Mansonia titil-
lans, Cx. (Mel.) spissipes, Coquillettidia aribalzagae, Ae.
scapularis,  Cx. (Mel.)  aikeni sensu lato (ocossa and
panocossa), and Psorophora albipes. Also, a large number
of unknown Cx. (Mel.) spp. belonging to the
Melanoconion Section were captured. No viruses were iso-
lated from mosquitoes; however, 2 of the most abundant
species, Cx. ocossa and Cx. panocossa, have been incrim-
inated as enzootic VEEV vectors and Ma. titillans and Ae.
scapularis were implicated as potential bridge vectors that
may export VEEV from sylvatic, enzootic foci in
Venezuela (31). However, typical epidemic vectors such as
Ae. taeniorhynchus and Ps. confinnis were not present.
Isolation and Genetic Analyses 
of VEEV Strains from Equines
Two equine brain specimens and 3 serum samples from
stablemates yielded mouse deaths with CPE-inducing
activity in brains. Antigenic analyses that used MAbs indi-
cated that all isolates belonged to subtypes IAB/C. Four
sequences of RT-PCR amplicons covering the PE2 gene
were identical to the subtype IC strains 6119 and 3908
from the 1995 epidemic, and also to the subtype IC strains
P676 and V198 from the 1962–64 epidemic (Table 5) (23).
The exception was strain 254818, isolated from a stable-
mate of a deceased horse in Carabobo State after strain TC-
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sequence identical to that of strain TC-83 (32), with the
exception of a single nucleotide difference at genome posi-
tion 8845 that encoded a Lys to Met change at E2 amino
acid position 115.
To increase phylogenetic resolution, the complete
genomes (excluding the 5′ terminal 20 nt that incorporated
PCR primers into amplicons) of representative strains
from Carabobo (255010) and Barinas States (254934)
were sequenced. The most closely related sequence to both
isolates was strain 6119, isolated in May, soon after the
beginning of the 1995 VEE epidemic in Falcon State. This
strain differed from strains 255010 and 254934 by only 1
and 4 nt, respectively. Slightly more distantly related was
strain 3908 from Zulia State in September 1995, followed
by strains from the 1962–64 Venezuelan/Colombian epi-
demic. Only 1-nt difference among the year 2000 and 1995
VEEV isolates encoded an amino acid difference; strain
254934 had Lys at E2 position 199, whereas all other
strains had Glu (Table 5).
Phylogenetic analyses that used all methods indicated
that strain 6119 had a sequence identical to the predicted
ancestor of strains 255010 and 254934, and branch lengths
indicated interepidemic evolutionary rates of 1.7–7.0 ×
10–5 substitutions/nucleotide/year. In contrast, during the
1995 outbreak, relative branch lengths of strains 6119 and
3908 indicated a faster evolutionary rate of 2.0 × 10–4 sub-
stitutions/nucleotide/year. Relative rate analyses of the
1962–64 epidemic clade resulted in similar estimates of
intraepidemic evolution from 2.2–4.4 × 10–4 substitu-
tions/nucleotide/year, similar to estimates of ≈3 × 10–4 sub-
stitutions/nucleotide/year for enzootic VEEV in Venezuela
(23). These data indicate that the subtype IC VEEV strains
persisted in Venezuela from 1995 to 2000 in a genetically
stable manner, with ca. 10-fold slower rates of nucleotide
substitution than are estimated to occur during epidemic or
enzootic circulation.
Discussion
Of 5 major hypotheses proposed to explain the
source(s) of strains of subtypes IAB and IC responsible for
all major VEE outbreaks (7), 2 are supported by previous
studies: 1) several of the later VEE outbreaks caused by
subtype IAB strains were probably initiated by the use of
incompletely inactivated vaccines produced from early,
wild-type, equine-virulent isolates (8,33); and 2) all sub-
type IAB and IC strains evolved independently from an
enzootic lineage of subtype ID VEEV that circulates in
western Venezuela, Colombia, and northern Peru (2,22).
Johnson and Martin (7) also hypothesized that epidemic
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mission cycles that have been overlooked, despite postepi-
demic surveillance in the affected areas of Colombia
(11,12) and Venezuela (12,34,35).
We report the first direct evidence that supports
postepidemic circulation of epidemic VEEV. During 2000
in western Venezuela, 5 years after the apparent end of the
1995 epidemic, 4 isolates of VEEV nearly identical to
1995 strains were associated with equine encephalitis in
Barinas and Carabobo States. Viral sequences had under-
gone virtually no evolutionary change during the interepi-
demic period, in contrast to epidemic and enzootic virus
circulation, in which a relatively steady rate of nucleotide
substitutions, on the order of 2–4 × 10–4 substitutions/
nucleotide/year, occurs (23,36). From 1995 to 2000, the
subtype IC strain underwent an ≈10-times slower evolu-
tion, which suggests less replication than normally occurs
in rodent reservoir or equine amplification hosts and mos-
quitoes during horizontal transmission.
Our seroprevalence data from bovines also suggest that
enzootic VEEV strains may have been circulating in the
affected regions. Although we did not identify bovine
serum that exhibited blocking activity solely against the
epidemic virus–specific MAb, some samples reacted in
both epidemic- and enzootic virus-specific ways. Larger
samples of bovine and rodent serum are needed to more
conclusively assess the subtype(s) of VEEV strains circu-
lating in the region.
Although we could not identify the critical reservoir
hosts and vectors that allow VEEV to persist in Barinas
State, the occurrence of equine cases at the end of the rainy
season and beginning of the dry season suggests funda-
mental differences from normal epidemic or enzootic cir-
culation. Epidemic VEE generally occurs during the peak
of the rainy season, when floodwater mosquitoes are abun-
dant. Although mosquito surveillance was not conducted
during the Barinas or Carabobo outbreaks, collections dur-
ing the same season in 2001 indicated relatively small pop-
ulations on the affected farms. Although our more recent
mosquito collections included known enzootic VEEV vec-
tors (Table 4), these mosquitoes are not known to transmit
epidemic virus strains, and we did not detect VEEV anti-
bodies in the rodents with which they are typically associ-
ated in sylvatic, enzootic foci. Typical epidemic vectors
were not abundant in the affected regions. These results
suggest the possibility that more xerophilic vectors other
than mosquitoes might have been responsible for subtype
IC VEEV maintenance and transmission to horses.
Ticks are susceptible to experimental infection by
VEEV, although rates of oral and transtadial transmission
tend to be low (37–39), and persistence for up to 171 days
has been demonstrated. The effect of persistent tick infec-
tion on alphavirus genome stability has not been evaluat-
ed, but alphavirus infection of mosquitoes involves early
replication for ≈1 week, followed by declining replication
due to poorly understood modulating factors that probably
include RNA interference (40). If similar mechanisms
occur in infected ticks, long-term persistence could result
in the levels of genetic stasis we observed in subtype IC
VEEV from 1995 to 2000. To evaluate this hypothesis,
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tor(s) and reservoir host(s) in Barinas State is ongoing.
Our results also call into question previous estimates of
alphavirus evolutionary rates that suggested a laboratory
source for the 1995 Venezuelan epidemic. The inconsisten-
cy between the genetic stasis observed in subtype IC
strains isolated from 1962–1964 versus 1995, and rates of
nucleotide substitution observed during enzootic or epi-
demic VEEV circulation, suggested a laboratory source for
the 1995 outbreak (23). The common use in Venezuela of
antigens prepared from a 1963 strain (P676), from which
active virus was isolated, and its similarity to the predicted
progenitor of the 1995 outbreak also supported this
hypothesis of a laboratory origin. We consider it highly
unlikely that the year 2000 Carabobo and Barinas out-
breaks resulted from laboratory strains because of the fol-
lowing factors: 1) in Venezuela, wildtype epidemic VEEV
strains have largely been replaced for antigen preparation
by the strain TC-83 vaccine virus to minimize the possibil-
ity of a laboratory-initiated outbreak; 2) the 2000 isolates
do not group phylogenetically with strain P676 as the 1995
strains do (Figure 2); and 3) unlike Falcon state, where the
1995 outbreak began, the locations of the 2000 outbreaks
are far from the diagnostic and vaccine production labora-
tories that work with VEEV. Also, the Instituto Nacional
de Investigaciones Agropecuarias, where the year 2000
VEEV strains were isolated, had not worked with subtype
IC VEEV for many months. Furthermore, the isolation of
the strain TC-83 virus from a stablemate of the
encephalitic horse at the Carabobo site during vaccination
efforts argues against any laboratory contamination with a
subtype IC strain. This evidence strongly suggests that the
2000 outbreaks involved naturally circulating VEEV
strains that were maintained in a genetically stable state
since 1995. Thus, based on genetic stasis and other factors,
the previous conclusion that the 1995 outbreak may have
had a laboratory origin, should be reevaluated. Since epi-
demic strains of VEEV can be maintained for at least 5
(1995–2000 or 2003) and possibly even 31 (1964–1995)
years between epidemics, equine vaccination efforts and
surveillance should be implemented continuously in
Venezuela and Colombia.
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